Here, we used mice with an inducible liver IGF-I deficiency to elucidate the role of IGF-I in experimental liver metastasis of colon and lung carcinoma cells, in particular its contribution to the host innate immune response engendered by the metastatic tumor cells. This evidence concerns the gene IGF1 and lung carcinoma.